2010•Practical Journal of Cardiac Cerebral Pneumal and Vascular DiseaseRequires access

The Value of Interleukin-6 and Plasma B-type Natriuretic Peptide in Patients with Acute Coronary Syndrome

HE Yun-fan

Open publisher page 0 citations

Abstract

Objective Probe into the value of interleukin-6 (IL-6) and plasma B-type natriuretic peptide (BNP) in diagnosis and therapeutic in acute coronary syndrome (ACS).Methods Choose 68 patients with ACS and measure their concentration of plasma interleukin-6 and BNP before and after PCI.Contrive non-ACS group 66 persons comparing with ACS group.Results The IL-6 and plasma BNP levels in patients with ACS were significantly higher than that of control group(P0.05).The difference of IL-6 and plasma BNP concentration between before and after PCI is Statistically significant(P0.05).Conclusion IL-6 and plasma BNP concentration is closely related to ACS and can be as important indicators for diagnosis and treatment in ACS.

About this research paper

What this paper is about

Objective Probe into the value of interleukin-6 (IL-6) and plasma B-type natriuretic peptide (BNP) in diagnosis and therapeutic in acute coronary syndrome (ACS).Methods Choose 68 patients with ACS and measure their concentration of plasma interleukin-6 and BNP before and after PCI.Contrive non-ACS group 66 persons comparing with ACS group.Results The IL-6 and plasma BNP levels in patients with ACS were significantly higher than that of control group(P0.05).The difference of IL-6 and plasma BNP concentration between before and after PCI is Statistically significant(P0.05).Conclusion IL-6 and plasma BNP concentration is closely related to ACS and can be as important indicators for diagnosis and treatment in ACS.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective Probe into the value of interleukin-6 (IL-6) and plasma B-type natriuretic peptide (BNP) in diagnosis and therapeutic in acute coronary syndrome (ACS).Methods Choose 68 patients with ACS and measure their concentration of plasma interleukin-6 and BNP before and after PCI.Contrive non-ACS group 66 persons comparing with ACS group.Results The IL-6 and plasma BNP levels in patients with ACS were significantly higher than that of control group(P0.05).The difference of IL-6 and plasma BNP concentration between before and after PCI is Statistically significant(P0.05).Conclusion IL-6 and plasma BNP concentration is closely related to ACS and can be as important indicators for diagnosis and treatment in ACS.

Key concepts: Medicine, Acute coronary syndrome, Natriuretic peptide, Internal medicine, Conventional PCI, Cardiology, Interleukin 6, Plasma concentration

Related papers

Back to paper searchBrowse research topicsOriginal source
The Value of Interleukin-6 and Plasma B-type Natriuretic Peptide in Patients with Acute Coronary Syndrome — Research Paper | ScholarLens